Marc Wirden
Impact in
- Virology top 0.2%
- HIV Research and Treatment
- Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- HIV/AIDS drug development and treatment 95
- HIV/AIDS Research and Interventions 56
- Virology 95
- HIV Research and Treatment 95
- Co-authors
- Vincent Cálvez (89 shared papers)Anne‐Geneviève Marcelin (87 shared papers)Christine Katlama (69 shared papers)Anne Simon (29 shared papers)Gilles Peytavin (28 shared papers)Isabelle Malet (20 shared papers)Cathia Soulié (36 shared papers)Marc‐Antoine Valantin (21 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (35 papers)AIDS (17 papers)Antimicrobial Agents and Chemotherapy (10 papers)Antiviral Therapy (7 papers)Journal of the International AIDS Society (5 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Marc Wirden
100 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 75
- Virology 1.7k
- Infectious Diseases 1.9k
- Hepatology 113
- Emergency Medicine 101
- Epidemiology 317
Countries citing papers authored by Marc Wirden
This map shows the geographic impact of Marc Wirden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Wirden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Wirden more than expected).
Fields of papers citing papers by Marc Wirden
This network shows the impact of papers produced by Marc Wirden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Wirden. The network helps show where Marc Wirden may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc Wirden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 220 | |
| 2 | 2003 | 99 | |
| 3 | 2003 | 83 | |
| 4 | 2020 | 77 | |
| 5 | 2009 | 76 | |
| 6 | 2011 | 65 | |
| 7 | 2009 | 64 | |
| 8 | 2005 | 60 | |
| 9 | 2010 | 45 | |
| 10 | 2006 | 44 | |
| 11 | 2004 | 44 | |
| 12 | 2003 | 41 | |
| 13 | 2005 | 39 | |
| 14 | 2012 | 37 | |
| 15 | 2011 | 36 | |
| 16 | 2013 | 36 | |
| 17 | 2009 | 35 | |
| 18 | 2004 | 30 | |
| 19 | 2013 | 29 | |
| 20 | 2017 | 28 |
About Marc Wirden
Marc Wirden is a scholar working on Infectious Diseases, Virology, Epidemiology, Molecular Biology and Emergency Medicine, having authored 105 papers that have together received 2.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (95 papers), HIV/AIDS drug development and treatment (95 papers), HIV/AIDS Research and Interventions (56 papers), Pneumocystis jirovecii pneumonia detection and treatment (11 papers), Biochemical and Molecular Research (9 papers), HIV-related health complications and treatments (7 papers), Hepatitis C virus research (7 papers) and Cytomegalovirus and herpesvirus research (6 papers). The work is most often cited by research in Virology (1.7k citations), Infectious Diseases (1.9k citations), Hepatology (113 citations), Emergency Medicine (101 citations) and Epidemiology (317 citations). Marc Wirden has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Vincent Cálvez, Anne‐Geneviève Marcelin, Christine Katlama, Anne Simon, Gilles Peytavin, Isabelle Malet, Cathia Soulié, Marc‐Antoine Valantin, Constance Delaugerre and Dominique Costagliola. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, AIDS, Antimicrobial Agents and Chemotherapy, Antiviral Therapy and Journal of the International AIDS Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.